SCHEMBL2907076

SCHEMBL2907076

COc1cccc(CC2(C(C(=O)NC3CCCCC3)C3CCCCC3)Nc3ccc(F)cc3N2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
POLB P06746 1/20 0.46
PKM P14618 1/20 0.45
HTT P42858 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 1/20 0.43
CASP1 P29466 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NFKB1 P19838 1/20 0.41
CASP3 P42574 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912844 0.92 LMNA (0.49) LMNAPOLBPKMHTTNPSR1
SCHEMBL2914853 0.87 MEN1 (0.46) LMNAPOLBNPSR1NPC1RAB9A
SCHEMBL2912392 0.87 EPHX2 (0.48) LMNANPC1RAB9AKMT2AMEN1
SCHEMBL2914348 0.83 LMNA (0.44) LMNAHTTNPC1RAB9ASMN1; SMN2
SCHEMBL3648565 0.83 MAPT (0.44) LMNAPOLBNPC1RAB9ASMN1; SMN2
SCHEMBL2912514 0.82 TP53 (0.40) LMNAPOLBNPC1RAB9ASMN1; SMN2
SCHEMBL3648088 0.82 MEN1 (0.48) POLBNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL4034659 0.81 NPC1 (0.43) HTTNPSR1NPC1RAB9ASMN1; SMN2
SCHEMBL3648571 0.81 HPGD (0.48) NPC1RAB9ACYP3A4CYP2C19ALDH1A1
SCHEMBL2912992 0.80 NPC1 (0.45) LMNAPOLBNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed